The stock of ReNeuron Group Plc (LON:RENE) is a huge mover today! The stock decreased 2.00% or GBX 0.05 on November 10, hitting GBX 2.45. About 4.23 million shares traded hands or 136.31% up from the average. ReNeuron Group Plc (LON:RENE) has declined 16.67% since April 11, 2016 and is downtrending. It has underperformed by 22.32% the S&P500.
The move comes after 5 months positive chart setup for the GBX 73.73 million company. It was reported on Nov, 10 by Barchart.com. We have GBX 6.17 PT which if reached, will make LON:RENE worth GBX 112.07 million more.
More news for ReNeuron Group Plc (LON:RENE) were recently published by: Uk.Finance.Yahoo.com, which released: “ReNeuron Group plc (RENE.L)” on March 29, 2014. Fool.Co.Uk‘s article titled: “Is ReNeuron Group Plc The Perfect Partner For BTG plc And Shire PLC In Your …” and published on June 22, 2015 is yet another important article.
ReNeuron Group plc is a clinical-stage company. The company has a market cap of 73.73 million GBP. The Company, through its subsidiaries, is engaged in researching and developing cell therapies. It currently has negative earnings. The Company’s products are allogeneic.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.